Evaluation of the anti-anginal efficacy and safety of oral administration of ivabradine compared to placebo on top of a background therapy with a calcium antagonist (amlodipine or nifedipine) in patients with stable angina pectoris: A 6-week, randomised, double-blind, parallel-group, international, multicentre study

Registry ID

EUCTR2006-006246-34

Source registry

EUCTR

Status

Completed

Phase

PHASE3

Sponsor

Institut de Recherches Internationales Servier

Start date

2007-11-28

Last update

2026-08-16

Conditions

• Stable angina pectoris

Summary

- To demonstrate that over a 6-week treatment period ivabradine is more efficacious than placebo when given in combination with calcium antagonists (amlodipine or nifedipine) in patients with stable chronic effort angina pectoris.

Locations

• , , Lithuania
• , , Slovakia
• , , Poland
• , , Latvia
• , , Bulgarian Drug Agency
• , , Estonia
• , , Hungary

View on source registry